mRNA-4157,Pembrolizumab
Moderna,Merck
['caveat', '$mrk', '$mrna']
 but i think the 12-mth rfs landmark &amp; inclusion of stage iv patients largely dismiss the underperformance argument (caveat, censoring) $mrna $mrk #aacr23 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.